SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Disco Pharmaceuticals to Receive $40 Million Upfront, Up to $2.5 Billion in Milestones

Under the terms, Disco Pharmaceuticals is eligible to receive up to $2.5 billion in milestone payments.

ABBV

Related stories